Bilaterality in papillary thyroid carcinoma: long-term outcomes and predictive factors.
[PURPOSE] Bilaterality in papillary thyroid carcinoma (PTC) is a critical factor influencing surgical approach selection.
- OR 4.58
APA
Zhang J, Fei M, et al. (2026). Bilaterality in papillary thyroid carcinoma: long-term outcomes and predictive factors.. Thyroid research, 19(1), 3. https://doi.org/10.1186/s13044-026-00285-8
MLA
Zhang J, et al.. "Bilaterality in papillary thyroid carcinoma: long-term outcomes and predictive factors.." Thyroid research, vol. 19, no. 1, 2026, pp. 3.
PMID
41526980
Abstract
[PURPOSE] Bilaterality in papillary thyroid carcinoma (PTC) is a critical factor influencing surgical approach selection. This study aimed to investigate the long-term outcomes and predictive factors associated with bilaterality in PTC.
[METHODS] This retrospective study reviewed 2,816 consecutive PTC patients who underwent total thyroidectomy between January 2013 and December 2015. Risk factors for bilaterality were analyzed using multivariate logistic regression. Among these, 1282 patients with ≥ 24-months follow-up were included in further recurrence/persistence analysis. The primary outcome measured was recurrence-free survival (RFS).
[RESULTS] Bilaterality was significantly associated with shorter RFS compared to unilateral PTC ( < 0.01), with a mean follow-up of 74.3 ± 33.3 months (median: 71 months; range: 24–140 months). Additionally, multifocality (OR = 4.58, < 0.01), advanced N stage (N1a: OR = 1.36, = 0.002; N1b: OR = 1.61, < 0.01), obesity (OR = 1.74, < 0.01), and a family history of thyroid cancer (OR = 2.16, < 0.01) were independent predictors of bilaterality.
[CONCLUSION] A comprehensive preoperative examination should be conducted to detect bilaterality, particularly in PTC patients with identified risk factors. Additionally, intensive postoperative follow-up is recommended for patients with bilaterality to monitor for recurrence/persistence.
[METHODS] This retrospective study reviewed 2,816 consecutive PTC patients who underwent total thyroidectomy between January 2013 and December 2015. Risk factors for bilaterality were analyzed using multivariate logistic regression. Among these, 1282 patients with ≥ 24-months follow-up were included in further recurrence/persistence analysis. The primary outcome measured was recurrence-free survival (RFS).
[RESULTS] Bilaterality was significantly associated with shorter RFS compared to unilateral PTC ( < 0.01), with a mean follow-up of 74.3 ± 33.3 months (median: 71 months; range: 24–140 months). Additionally, multifocality (OR = 4.58, < 0.01), advanced N stage (N1a: OR = 1.36, = 0.002; N1b: OR = 1.61, < 0.01), obesity (OR = 1.74, < 0.01), and a family history of thyroid cancer (OR = 2.16, < 0.01) were independent predictors of bilaterality.
[CONCLUSION] A comprehensive preoperative examination should be conducted to detect bilaterality, particularly in PTC patients with identified risk factors. Additionally, intensive postoperative follow-up is recommended for patients with bilaterality to monitor for recurrence/persistence.
같은 제1저자의 인용 많은 논문 (5)
- Mitochondria in situ releasing corosolic acid enhanced antitumor effects via activating mitophagy in castration-resistant prostate cancer.
- [Exploring the intervention mechanism of modified Danggui buxue decoction on neuroinflammation in CIPN model mice based on transcriptomics and network pharmacology].
- Injectable HMME-Loading Emulsion Hydrogel for Ultrasound-Triggered Release and Enhanced Sonodynamic Immunotherapy.
- Identification of a 9-gene autophagy-related signature for predicting prognosis and immune exhaustion features in breast cancer.
- Innovative approaches for lung cancer screening and interception.